Aditxt, Inc. Customer Funds
Aditxt, Inc. (ADTX) had Customer Funds of $51.50 million as of 2022-12-31, per its 10-K filed 2023-04-17.
Discontinued › Notes › and Other Assets
us-gaap:CustomerFunds · last filed 2023-04-17
- 2022-12-31: Customer Funds $51.50M.
- 2022-09-30: Customer Funds $67.30M.
- 2022-06-30: Customer Funds $67.30M.
- 2022-03-31: Customer Funds $67.30M.
| Period end | Customer Funds |
|---|---|
| 2022-12-31 | $51.50M 10-K · filed 2023-04-17 |
| 2022-09-30 | $67.30M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $67.30M 10-Q · filed 2022-08-15 |
| 2022-03-31 | $67.30M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $67.30M 10-K · filed 2022-03-31 |
| 2021-09-30 | $89.00M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |